E

Elgene Lim

Professor

University of New South Wales (UNSW) · Medicine & Health

Status Unknown
53
H-index
357
Papers
16,090
Citations
—
Active Grants

Research Areas

Advanced Breast Cancer TherapiesBreast Cancer Treatment StudiesHER2/EGFR in Cancer ResearchCancer-related Molecular PathwaysCancer Cells and Metastasis

Potential Research Topics

  • • Advanced Breast Cancer Therapies
  • • Breast Cancer Treatment Studies
  • • HER2/EGFR in Cancer Research

Recent Publications

Palbociclib for Hormone-Receptor-Positive, HER2-Positive Advanced Breast Cancer.

The New England journal of medicine202624 citationsDOI ↗

Loss of luminal lineage drives resistance to next-generation ERα antagonists in pretreated ER+ HER2− locally-advanced or metastatic breast cancer

Nature Communications20262 citationsDOI ↗

Abstract GS3-06: Rb Functions as a Transcriptional Activator of ER Targets Following CDK4/6 Inhibition in Luminal Breast Cancer

Clinical Cancer Research20261 citationsDOI ↗

Stromal Cell Subsets Modulate T-cell Infiltration in Early Breast Cancer

Cancer Research Communications20261 citationsDOI ↗

Abstract PD5-08: Circulating Tumour DNA (ctDNA) Dynamics From Patients With ER+, HER2- Advanced Breast Cancer in the Phase 3 EMBER-3 Trial

Clinical Cancer Research20261 citationsDOI ↗

AI Summary

AI

Elgene Lim是新南威尔士大学(UNSW)的教授,在乳腺癌治疗研究领域具有深厚的学术积累,研究范围涵盖HER2/EGFR信号通路、癌症分子机制及转移机理等关键方向。凭借357篇学术论文和超过16000次引用记录(H-Index 53),Lim教授在癌症生物学领域享有极高的学术声誉,其研究成果对于从事肿瘤相关PhD研究的申请者具有重要的学习参考价值。有志于深化癌症治疗或分子病理学研究的学生可重点关注其最新研究进展和发表成果。

Interested in working with Elgene Lim?

Chat with Ola about this Professor →

Powered by Koala PhD